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Article Information  ABSTRACT 
Received: 27th July 2018  A few five members’ aromatic systems having three hetero-atoms at symmetrical positions, for 
example, thiadiazoles have been considered broadly attributable to their intriguing 
pharmacological properties. These thiadiazole derivatives are the heterocyclic compound which 
contains the five member ring along with nitrogen and sulfur atoms. This recent study covers the 
most dynamic thiadiazole subordinates that have demonstrated significant biological activities, 
for example, anti microbial, anti inflammatory, anti tubercular, ant-diabetic, diuretics, anti 
depressant, radio-protective, anti-leishmanial and cytotoxic activity.  
This review likewise examines the structure-activity relationship (SAR) of the most powerful 
compounds. It can go about as an imperative tool for restorative scientists to create more current 
compounds having thiadiazole moiety that could be better operators regarding viability and 
safety. 
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INTRODUCTION 
In all cases against disease block, the ascent of new pathogens 
despite the resurgence of old ones and the nonappearance of 
incredible new therapeutics compound the issues of 
antimicrobial obstruction [1].The need to structure new 
compounds to manage this opposition has turned out to be a 
standout amongst the most imperative regions of research 
today. Thiadiazole is an adaptable moiety that displays a wide 
assortment of biological action most likely uprightness of – 
N=C-S-gathering [2]. Thiadiazole moiety goes about as 
‘hydrogen restricting space’ and ‘two-electron contributor 
system’. It additionally goes about as a compelled 
pharmacophore. Numerous medications containing thiadiazole 
core are accessible in the market, for example, acetazolamide, 
methazolamide, sulfamethazole, and so forth. 
Thiadiazole derivatives can likewise go about as the bio-
isosteric substitution of the thiazole moiety. So it acts like third 
and fourth era cephalosporins, subsequently can be utilized in 
anti-microbial arrangements. Amid the second 50% of the 
twentieth century a wide range of subsidiaries were blended 
dependent on this structure.The late writing is enhanced with 
dynamic discoveries about the union of 1, 3, 4-thiadiazole 
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moiety and their expansive range of pharmacological activities, 
for example, antibacterial [3], fungicidal [4], anti-inflammatory 
[5], antidepressant [6], antioxidant properties [7], anticancer 
[8], carbonic anhydrase inhibiting effect [9] and so on. 1,3,4-
thiadiazole subsidiaries forces intriguing biological activity 
presumably gave to them because of solid aromaticity of the 
ring system which prompts incredible in-vivo dependability and 
for the most part, an absence of toxicity for higher vertebrates, 
including people when differing utilitarian gathering that 
collaborate with biological receptor are connected to aromatic 
ring [10]. Way to deal with routine with regards to therapeutic 
science has created from an observational one including 
synthesis of new organic compounds dependent on change of 
chemical compounds of realized organic exercises could be 
better investigated. It is entrenched that slight modification in 
the structure of specific compounds can convey extreme 
changes to yield better medication with less poisonous quality 
to the host it saw that concoction alteration modifies 
physiochemical properties as well as pharmacological 
properties [11]. 
 
Chemistry of Thiadiazole [12]: 
An ongoing writing review uncovered that the 1, 3, 4-
thiadiazole moiety has been generally utilized by the 
therapeutic scientific expert in the past to investigate its natural 
exercises. The advancement of 1, 3, 4-thiadiazole science is 
connected to the disclosure of phenylhydrazines and hydrazine 
in the late nineteenth century. The initial 1, 3, 4-thiadiazole was 
depicted by Fischer in 1882, yet the genuine idea of the ring 
framework was shown first in 1890 by Freund and Kuh. 
Thiadiazole is a five member ring framework containing sulfur 
and nitrogen atom. They happen in four isomeric forms viz., 1, 
2, 3-thiadiazole (1), 1, 2, 4-thiadiazole (2), 1, 2, 5-thiadiazole 
(3), 1, 3, 4-thiadiazole (4). Their dihydro derivative gives 
greater part of writing on thiadiazole. 
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The numbering of monocyclic azole framework starts with the 
heteroatom that is in the most noteworthy gathering in the 
periodic table and with the component of least atomic weight in 
that group.Hence, the numbering of 1, 3, 4-thiadiazole (Figure 
1) is done in the following manner. This designated that one 
sulphur group is present in the ring. 
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Fig.1. Structure of Thiadiazole moiety 
 
ANTIMICROBIAL ACTIVITY 
Upadhyay and Mishra et. al., integrated the 5-(4-substituted 
phenyl)- 1, 3, 4-thiadiazol-2-amine subordinates 8 and 
performed in-vitro antibacterial movement against S. aureus, 
Bacillus subtilis, Escherichia coli and Pseudomonas 
aeruginosa; antifungal movement against Aspergillus niger and 
Candida albicans by disk diffusion technique. Pretty much 
every one of the compounds, Fluorinated and chlorinated mixes 
8a and 8b indicated great inhibitory impacts (hindrance 
somewhere in the range of 81% and 91%) with minimum 
inhibitory concentration (MIC) estimations of 20-28 μg/mL 
(controlled to ciprofloxacin, MIC =18-20 μg/mL) for S. 
aureus and B. subtilis. Moreover, halogenated compounds 8a-
8c and hydroxyl derivative 8d demonstrated moderate 
inhibitory impacts (hindrance somewhere in the range of 58% 
and 79%) with MIC estimations of 24-40 μg/mL (controlled to 
ciprofloxacin, MIC =20-24 μg/mL) for E. coli and P. 
aeruginosa. Huge antifungal action against A. niger and C. 
albicans was shown by subsidiaries 8d and 8e bearing 
oxygenated substituents at phenyl ring (hindrance somewhere 
in the range of 58% and 66% and MIC =32-42 μg/mL 
contrasted with fluconazole, MIC =24– 26 μg/mL). It creates 
the impression that the halogen joined to the phenyl-1, 3, 4-
thiadiazol moieties expands the antibacterial movement with 
inclination against Gram-positive microbes, while the 
oxygenated substituent gives antifungal action [13]. 
 
(8) 
R=F (a), Cl (b), Br (d), OH (d), OCH3 (e) 
Andrews et al.,
 
synthesized 2-amino-1, 3, 4-thiadiazole 
derivatives and were evaluated for in- vitro antibacterial 
activity at a concentration of 10 μg/mL by measuring the 
inhibition area on agar plates (disk diffusion method). However 
nitro derivatives  36c-36d, were shown moderate activity 
against E. coli  by using ciprofloxacin as standard drug. 
Hydroxyl derivatives 36a-36b exhibited moderate to good 
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inhibitory activity against P. aeruginosa, S. aureus and E. coli 
[14]. 
 
(36) 
X=O, S 
R=OH,    R1=H (a, b) 
R=H       R1=NO2 (c, d) 
The in-vitro antimicrobial action of some new 1,3,4-thiadiazole 
derivatives, for example, 12 having a D, L-methionine moiety 
has been assessed against a few bacterial strains by Pintilie et. 
al [15]. From the discoveries, the authors uncovered that 1, 3, 
4-thiadiazole derivatives have great action against Bacillus 
anthracis and Bacillus cereus, the most dynamic compound 
12c having a 4-methylphenyl moiety on the heterocyclic ring. 
The compounds demonstrated an extremely feeble movement 
against S. aureus and E. coli strains and were idle against 
Sarcina lutea strain. 
The antimicrobial movement of some thio-ethers got from 2-
amino-5-mercapto-1, 3, 4-thiadiazole was observed to be 
subject to the substitution at the mercapto grouping. Despite the 
fact that all the tried compounds indicated moderate 
antibacterial action against gram-positive and gram-negative 
bacterial strains and moderate to great antifungal action against 
C. albicans, the discoveries uncovered that the antimicrobial 
movement was enhanced by the presentation of a 1-
arylethanone moiety at the mercapto gather [15]. 
Rad et al., found that the unsubstituted and halogenated aryl 
derivatives 13 turned out to be the most dynamic compound 
against Salmonella typhimurium and C. albicans [16]. 
             
(12)     (13) 
R= CH3 (a), C6H5 (b) , 4-CH3C6H5 (c) , Ar = napthyl , 4-ClC6H4, C6H5  
4-Br C6H4 (d), H2C=CHCH2 (e) 
 
Noolvi et. al., 2016, were synthesized a series of 1, 3, 4-
thiadiazole derivatives of [2-(4-formyl-2-methoxyphenoxy) 
acetic acid] (6a-6s) by cyclization of carboxylic acid group of 
[2-{2-methoxy-4-(3-oxo-3-substituted phenylprop-1-enyl) 
phenoxy} acetic acid] (4a-4s) with thiosemicarbazide in 
presence of POCl3 or PPA [17].  The structures of all the tested 
compounds were confirmed by IR, 
1
H NMR and mass analysis. 
The synthesized compounds have been evaluated for their in-
vitro antimicrobial activities against several strains of microbes 
and showed significant microbial activity. 
 
R= H, 2-OCH3, 2,4-di-Cl, 3-NH3, 3-NO2, 4-OCH3, 4-F, 4-NO2, 4-Br, 
     4-CH3, 3-OH, 4-Cl, 2-NH2, 2, 4-di-OH, 4-NH2, 2-Cl, 4-OH, 3-CH3 
 
A new series of substituted 1, 3, 4-thiadiazoles were 
synthesized by Rezki et. al., combining the xylosyl moiety and 
the aryltetrazole ring gave compound 27 which exhibiting S. 
aureus inhibitory activity.It is notable that furan derivatives 
bearing a nitro gather in the 5th-position and a grouping of the 
general type −C=N−N=C−, which might be consolidated in a 
heterocycle, have in-vivo antibacterial properties [18]. 
. 
(27) 
Some novel tetra Schiff bases were synthesized by Yousif et 
al., condensation of [1, 2, 4, 5- tetra (5-amino-1, 3, 4-
thiadiazole-2-yl) benzene] with different aromatic aldehydes 
[19]. All tested compounds (2a-2h) were screened for their 
antibacterial (Staphylococcus aureus, Staphylococcus 
epidermidis, icrococcus luteus, Bacillus cereus, Escherichia 
coli, and Pseudomonas aeruginosa) and antifungal (Aspergillus 
niger and Aspergillus fumigatus) activities. Among the 
synthesized compound 2g and compound 2h were found 
promising compounds of the series.   
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2(a-h) 
R=H, p-CH3, p-OH, p-OH, o-OH, p-NO2, p-Br,  p-OCH3, p-Cl 
 
Eight different 2, 5-disubstituted 1, 3, 4-thiadiazoles were 
prepared by Nayak et. al., using different aromatic or aliphatic 
carboxylic acids (1) and thiosemicarbazide (2) by conventional 
and microwave irradiation (MWI) methods. All the synthesized 
compounds were evaluated for their antimicrobial activity 
against Staphylococcus aureus. Escherichia coli, and 
Pseudomonas aeugenosa. Some of the synthesized compounds 
were shows mild to moderate activity, but not comparable with 
the Oflaxacin (standard). 
 
 
R=H, -CH3, C6H5, 4-NO2 C6H4, 4-CH3 C6H4, 
2-OH C6H4, 4-NH2 C6H4, 2-OCOCH3 C6H4 
Baghel et. al., were synthesized new series of thiadiazole 
derivatives and all the newly synthesized compounds were 
screened for their antibacterial activity against gram positive 
species [Bacillus subtilis, Staphylococcus aureus], gram 
negative species [Pseudomonas aeruginosa, E. coli ] and 
antifungal activity against Candida albicans, A. niger . Among 
the synthesized compound 5c and 5e were shows potent 
activity against the test organisms. Test compounds having 
substituted phenyl ring were found to be more biological active 
and as well as substituted with electron withdrawing groups 
gives highest antimicrobial activity [21]. 
 
5(a-e) 
 5a 5b 5c 5d 5e 
Ar 
 
 
 
 
 
R H -Cl -OH -NO2 -OH 
Raj et. al., were synthesized novel thiadiazole derivatives by 
reaction of substituted aromatic benzoic acid and 2- 
hydroxybenzoic acid with thiosemicarbazide to synthesize [5-
phenyl-1, 3, 4-thiadiazol-2-amine] (A) and [2-(5-amino-1,3,4-
thiadiazole-2-yl) phenol] (B). From these compounds various 
derivatives of 1, 3, 4-thiadiazole derivatives (A1-A4 and B1-
B4) have been synthesized [22]. All the synthesize compounds 
were screened for their antibacterial (Staphylococcus aureus , 
Becillus Cereus , Escherichia coli, Pseudomonas aeruginosa  
and anti-fungal (Aspergillus niger  and Aspergillus fumigatus ) 
activity by paper disc diffusion technique. 
 
R=H, OH 
R
1
= , , ,  
A series of α bromoketones and thiadiazole derivative were 
synthesized by Mendhe et. al., in 2012, [23]. The structure of 
all the synthesized compounds were confirmed by physical 
parameters like Melting point solubility etc, chromatographic 
methods (TLC) and spectroscopic methods such as IR, NMR. 
All the test compounds were screened for their antibacterial 
and antifungal activity by zone of inhibition method. 
Substituted thiadiazole derivatives (IIa, IIb, IIc and IId) showed 
significant activities compared to the standards ciprofloxacin 
for significant activity against E. coli and S. aureus at 50, 
100,300 and 500 mcg/mL and Miconazole significant activity 
against Candida albicans at 50, 100, 300,500 mcg/mL.  
.  
R = H, Cl, Br, NO2 
New 1, 3, 4-thiadiazole derivatives such as 46 incorporating a 
fluorobenzothiazole moiety have been synthesized by 
Vedavathi et.al [24]. From the results of antimicrobial 
assessment it has been found that some of the studied 
compounds (eg, morpholine and piperazine derivatives) 
showed significant antibacterial and antifungal activity. 
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(46) 
R= morpholinyl; piperazinyl 
Kallur et. al., 2012, synthesized some thiadiazole 
derivatives,the majority of 1, 3, 4-thiadiazoles are based on the 
cyclisation of thiaosemicarbazide derivative incorporating this 
basic structural unit.  All the derivatives were used for 
screening their antimicrobial activities against Bacillus subtilis, 
Bacillus pumilus, E coli and Pseudomonas aureginosa  by disc 
diffusion method using ciprofloxacin as a standard. 
Compounds MY 3b, MY 3c, MY 3d, and MY 3I were 
exhibited a broad spectrum antibacterial activity. While other 
synthesized compounds of this series shown poor antibacterial 
activity [25]. 
 
R= C6H5; p-ClC6H4; P-CH3C6H4 
R
1
= C6H5; p-ClC6H4; P-CH3C6H4 
A new series of 1, 3, 4-thiadiazoles were synthesized via 
reaction of 1, 3, 4-thiadiazolenaminones (1) with N-phenyl 2-
oxopropanehydrazonoyl chloride (2) in dioxane in the presence 
of triethylamine by Farghaly et al., [26]. Also, some new 
heterocycles incorporating 1, 3, 4-thiadiazole ring were 
obtained by reaction of 1, 3, 4-thiadiazolenaminones 1with 
nitrogen-nucleophiles like hydrazine hydrate, 3-amino-1, 2, 4-
triazole and 2-aminobenzimidazole. 
 
The relation between the structure of the products and their 
activity towards some microorganisms such as Aspergillus 
fumigatus , P. italicum , Geotrichum candidum , and Candida 
albicans  as well as four bacteria species, namely, gram 
positive bacteria, Staphylococcus aureus  and Bacillus subtilis , 
gram negative bacteria, Pseudomonas aeruginosa and 
Escherichia coli were studied and to get the promising results .  
 
Among all the compounds, 4a and 4b have high potency 
towards Staphylococcus aureus, Bacillus subtilis and 
Pseudomonas aeruginosa respectively. 
 
(4) 
Salih et. al., were prepared [{5-(p-Substituted phenyl)-N-(3-(5-
nitrofur-2-yl)-allylidene}-1, 3, 4-thiadiazol-2-amines] (10-17) 
by utilizing different p-substituted benzoic acid through two 
step reactions. Compound 2- amino-5-substituted-1, 3, 4-
thiadiazoles (2-9) derivatives was prepared by the reaction 
between thiosemicarbzide and benzoic acid derivatives in the 
presence of phosphorus oxychloride and followed by 5-nitro-2-
furanacrolein to yield the target products. The final structures 
of all the synthesized compounds were confirmed on the basis 
of their elemental analysis, spectral analysis  (IR, 
1
H NMR, 
13
C 
NMR, mass spectra) and  the synthesized compounds were 
screened for their antimicrobial activities [27]. From the 
preliminary results it has been found that some of the 
compounds exhibited promising antimicrobial activities. 
 
Ar = C6H5, p-CH3C6H4, p-CH3O C6H4,  p-OH C6H4, 
p-NO2 C6H4, p-Br C6H4 , p-I C6H4, p-Cl C6H4 
Sen et. al., have been synthesized some new benzotriazole 
derivatives (6) by conventional as well as eco-friendly 
microwave irradiated synthesis method and followed by 
antimicrobial evaluation against Escherichia coli, 
Staphylococcus aureus,  Klebsiella pneumoniae and Bacillus 
substilis [28]. 
 
(6) 
Singh et. al., [29] have been synthesized some 2, 5-
Disubstituted 1, 3, 4-thiadiazoles from different acids. All 
newly synthesized compounds were evaluated by the 
antimicrobial activity using Staphylococcus aureus (Gram+ve), 
B.Subtilis (Gram+ve), P.aeuroginosa (Gram-ve) and 
Escherichia coli (Gram-ve) by cup plate agar diffusion method 
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by measuring the inhibition zone in mm. From this study, it has 
been found that substituted 1, 3, 4- thiadiazole derivatives 
played a vital role as antibacterial agents. 
 
R 
 
 
  
R
1
 
  
 
 
Madhav and his colleagues were synthesized some new series 
of 1, 3, 4-thiadiazole derivatives (8) and further screened for 
their antimicrobial activity [30] against different gram positive 
and gram negative bacteria as well as some fungal strain.  
 
(8) 
Sah et al., [31] were synthesized a series of 5-(4-chlorophenyl 
amino)-2-mercapto-1, 3, 4- thiadiazole derivatives. The 
compounds (1a-1g) were tested for their in vitro antimicrobial 
activity against the two pathogenic bacterial strains eg., 
Escherichia coli and Salmonella typhi, three fungal strains eg., 
Aspergillus niger, Penicillium species and Candida albicans. 
The results of the antimicrobial evaluation have been revealed 
that some of the synthesized compound showed moderate 
activity. 
 
1(a-b) 
R=4-NO2, 2-CH3-4-NO2 
 
1(c-e) 
R=2-Cl; R1=OH, NH2, guanidine 
 
1(f-g) 
R= 3-OCH3, 4-OH; 
R1=pyrimidine, 4, 6-dimethyl pyrimidinyl 
1, 3-thiazolidin-4-one derivatives of 2-mercapto-5-methyl 1, 3, 
4-thiadiazole (11) and their derivatives were synthesized by 
Srivastava et. al., and further evaluated for their antimicrobial 
activity against B. substilis, E. coli,  K. pneumonia and S. 
aureus bacteria and antifungal activity against A. niger, A. 
flavus, F. oxisporium and T. viride fungi respectively [32]. 
Some of the tested compounds displayed marked antifungal 
activity against A. niger. 
 
 
S. Cherkupally et. al., synthesized a series of bis-[thiadiazol-2-
yl-tetrahydro-2-hpyrazolo-[ 3, 4-d] [1, 3]-thiazole] methanes 
and evaluated for in vitro antibacterial activity against some 
Gram  positive viz. Bacillus subtilis, Staphylococcus aureus 
and Micrococcus luteus, and Gram negative bacteria Proteus 
vulgaris, Salmonella typhimurium and Escherichia coli [33]. 
The compounds showed significance antimicrobial activity 
against above bacterial and fungal strain. 
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A variety of nitroaryl-1, 3, 4-thiadiazole derivatives(8a-8f)  
have been successfully synthesized by Jazayeri et al., [34]  in 
appreciable yields and screen for their antimicrobial evaluation 
against both gram positive and gram negative bacteria 
including Staphylococcus aureus, Staphylococcus epidermidis, 
Streptococcus pneumonia, Bacillus subtilis, Enterococcus 
faecalis, Micrococcus luteus and Gram-negative including 
Escherichia coli, Salmonella typhi, Shigella flexneri, Klebsiella 
pneumonia, Serratia marcescens and Pseudomonas 
aeruginosa.All the synthesized compound give good to 
moderate antimicrobial response against the selected 
organisms. 
 
8(a-f) 
Cpd. No. 8a 8b 8c 8d 8e 8f 
Ar-NO2 
 
 
 
 
 
 
 
Patel et. al., have been synthesize metal chelates of {5-[4-
chlorophenyl-(1, 3, 4)-thiadiazol-2-ylaminomethylene]-8-
hydroxy quinoline} (7) and evaluated for their anti-microbial 
activity [35] agains some gram positive and gram negative 
microorganisms. All the tested compound exhibited 
pronounced antibacterial activity against the gram-(+) ve 
bacteria and moderate poor activity against gram-(-) ve 
bacteria. 
 
(7) 
Various substituted triazolo-thiadiazoles (36-37) were 
synthesized by Prasad et. al., and  evaluated for their 
antibacterial and antifungal activity against the gram-(+)ve 
bacteria and moderate poor activity against gram-(-) ve 
bacteria. The preliminary results revealed that some of the 
compounds exhibited promising antimicrobial activities [36] 
 
(36) 
 
(37) 
R= 2, 3, 4-Cl-C6H2, 4-OH-C6H4, 4-Br-C6H4,  4-F-C6H4, 4-NO2-
C6H4, CH2-C6H4 
Foroumadi et. al., have been synthesized a series of 5-
(nitroaryl)-1, 3, 4-thiadiazoles (3-4) bearing certain sulfur 
containing alkyl side chain similar to pendent residue in 
tinidazole molecule and evaluated for their antibacterial, 
antifungal and cytotoxic effects respectively. Test compounds 
were found to be more potent against both gram positive and 
gram negative as well as fungal strain due to presence of 2-[2 
(ethylsulfonyl) ethylthio]- side chain [37].  
 
               (3)                                               (4) 
Ar = 5-nitrothiophene-2-yl; 5-nitrofuran-2-yl; 1-methyl-5-
nitroimidazol-2-yl; nitrophenyl 
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Different 4-amino-2-{5-[(4-substituted phenyl) amino]-1, 3, 4-
thiadiazole-2-yl} phenol (38a-38g) were incorporated and 
screened for their antibacterial and antifungal action by 
Hussain et.al. The tested compounds demonstrated huge 
antibacterial action against S. aureus (gram+ve) and E.coli 
(gram-ve) microscopic organisms and antifungal action against 
A. niger growths utilizing cup plate method. Compounds 38c, 
38e and 38f were observed to be great antibacterial progress 
against S. aureus (gram+ve) and E.coli (gram-ve) microbes and 
antifungal movement against A. niger (MIC value 25µg/mL) 
[38]. 
 
38a-38g 
 
 
Liu et al., have been synthesized some novel sulfoxide 
derivatives containing trimethoxyphenyl substituted 1, 3, 4-
thiadiazole moiety (32) and evaluated for their antimicrobial 
activity. The bioassay results revealed that synthesized 
compounds were possessing greater antifungal activities with 
EC50 values ranging from 19.91 μg/mL to 63.97 μg/mL 
respectively [39]. 
 
 
R=C6H5CH2-, CH3CH2COOCH2-, OCH3C6H4CH2-, 
NO2C6H4CH2-, FC6H4CH2-,-CH2CH2OCH2CH3 
A new 2-benzamide-5- alkenyl/hydroxyalkenyl-1, 3, 4-
thiadiazoles (21) have been synthesized from fatty acid 
hydrazides by Banday et. al. All the synthesized compounds 
were screened for their antimicrobial activity and the bioassay 
results displayed the marked antibacterial activity [40] against 
preferred organisms. 
 
R= CH2= CH (CH2)8, CH3 (CH2)7CH=CH(CH2)7, 
CH3 (CH2)5 CH (OH) CH2CH= CH (CH2)7, 
CH3 (CH2)4CH= CH (CH2)2 CH (OH) (CH2)7 
 
CONCLUSION 
The plenty of research bought in this review demonstrates a 
wide range of pharmacological exercises displayed by 1, 3, 4-
thiadiazoles derivatives. The organic profiles of these new ages 
of thiadiazoles would speak to a productive lattice for further 
advancement of better therapeutic specialists. 
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